Discover

MNKD
MannKind Corporation
3.91
18 x 3.91
23 x 3.92
bid
ask
-
0.02
0.47%
01:34 PM
timesize
Ytd-31.01%
1y14.38%
3.86
day range
3.98
2.23
52 week range
6.51
Open3.94Prev Close3.93Low3.86High3.98Mkt Cap1.25B
Vol1.74MAvg Vol5.22MEPS-0.13P/E-30.08Forward P/E33.33
Beta1.12Short Ratio5.19Inst. Own58.18%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0550-d Avg3.92200-d Avg4.291yr Est7.97

MNKD News

MannKind Corporation (MNKD) Q2 2026 Earnings Call Transcript
seekingalpha.com
MannKind Corporation (MNKD) Q2 2026 Earnings Call Transcript

MannKind Corporation (MNKD) Q2 2026 Earnings Call Transcript

MannKind Q2 Earnings Call Highlights
marketbeat.com
MannKind Q2 Earnings Call Highlights

MannKind NASDAQ: MNKD reported second-quarter revenue of $109.4 million, up 43% from the prior-year

Compared to Estimates, MannKind (MNKD) Q2 Earnings: A Look at Key Metrics
zacks.com
Compared to Estimates, MannKind (MNKD) Q2 Earnings: A Look at Key Metrics

The headline numbers for MannKind (MNKD) give insight into how the company performed in the quarter

MannKind (MNKD) Reports Q2 Loss, Beats Revenue Estimates
zacks.com
MannKind (MNKD) Reports Q2 Loss, Beats Revenue Estimates

MannKind (MNKD) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimat

MannKind Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
MannKind Reports Second Quarter 2026 Financial Results and Provides Business Update

Achieved three major catalysts to drive future growth: Launched the pediatric indication of Afrezza

MannKind Corporation (MNKD) Discusses Phase 1b Results and Clinical Progress of Nintedanib DPI for IPF Transcript
seekingalpha.com
MannKind Corporation (MNKD) Discusses Phase 1b Results and Clinical Progress of Nintedanib DPI for I

MannKind Corporation (MNKD) Discusses Phase 1b Results and Clinical Progress of Nintedanib DPI for I

MannKind's Inhaled IPF Drug Clears Phase 1b Safety Hurdle, Phase 2 Underway
marketbeat.com
MannKind's Inhaled IPF Drug Clears Phase 1b Safety Hurdle, Phase 2 Underway

MannKind NASDAQ: MNKD reported Phase 1b results for its inhaled nintedanib dry-powder inhalation, or

MannKind injection helps heart failure patients avoid ER infusions
reuters.com
MannKind injection helps heart failure patients avoid ER infusions

We also report on an experimental diagnostic approach that can ​detect tuberculosis exposure and inf

MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF
globenewswire.com
MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Ninteda

MNKD Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety & Tolerability of Nintedanib DP

MannKind to Report Second Quarter Financial Results and Host Conference Call on August 5, 2026
globenewswire.com
MannKind to Report Second Quarter Financial Results and Host Conference Call on August 5, 2026

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation

MannKind (NASDAQ:MNKD) Shares Gap Up   – Still a Buy?
defenseworld.net
MannKind (NASDAQ:MNKD) Shares Gap Up – Still a Buy?

MannKind Corporation (NASDAQ: MNKD - Get Free Report)'s stock price gapped up prior to trading on Fr

FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease
benzinga.com
FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease

Mannkind Corporation (NASDAQ:MNKD) shares are trading higher as the company recently announced the U

MannKind Corporation (MNKD) Discusses FDA Approval of Furoscix ReadyFlow for IV-Equivalent Diuretic Therapy in Fluid Overload Transcript
seekingalpha.com
MannKind Corporation (MNKD) Discusses FDA Approval of Furoscix ReadyFlow for IV-Equivalent Diuretic

MannKind Corporation (MNKD) Discusses FDA Approval of Furoscix ReadyFlow for IV-Equivalent Diuretic

MannKind Wins FDA Approval for Furoscix ReadyFlow, Secures $50M PIPE
marketbeat.com
MannKind Wins FDA Approval for Furoscix ReadyFlow, Secures $50M PIPE

MannKind NASDAQ: MNKD said the U.S. Food and Drug Administration approved Furoscix ReadyFlow, an aut

MannKind Announces $50 Million Private Placement
globenewswire.com
MannKind Announces $50 Million Private Placement

DANBURY, Conn. and WESTLAKE VILLAGE, Calif.

MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease
globenewswire.com
MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering I

MannKind announces FDA approval of Furoscix ReadyFlow™, the first & only autoinjector delivering IV-

What This MannKind Filing Reveals About Three Years of Underperformance
fool.com
What This MannKind Filing Reveals About Three Years of Underperformance

This MannKind insider filing details the disposition of 46,795 shares. The transaction reduced the i

What This MannKind Director Sale Signals With $32.7 Million in Quarterly Royalties Revenue Potentially at Risk
fool.com
What This MannKind Director Sale Signals With $32.7 Million in Quarterly Royalties Revenue Potential

The transactions involved 76,880 shares with a total value of about $313,000, based on a weighted av

What This MannKind Sale Signals With Tyvaso Royalties at $32.7 Million
fool.com
What This MannKind Sale Signals With Tyvaso Royalties at $32.7 Million

David Thomson disposed of 123,000 shares at $4.08 per share, representing a total transaction value

Why This MannKind Insider Stock Sale Matters Less Than a 9% Royalty at Risk
fool.com
Why This MannKind Insider Stock Sale Matters Less Than a 9% Royalty at Risk

This filing reported an insider's total disposition of 65,808 shares for an estimated value of $269,

Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga.com
Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures up, Dow futures gain 0.1% as Snap (NYSE: SNAP) shares fall 10.5%, Fastly (NASDAQ:

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Earnings Scheduled For May 6, 2026
benzinga.com
Earnings Scheduled For May 6, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday

Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Earnings Scheduled For November 5, 2025
benzinga.com
Earnings Scheduled For November 5, 2025

benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga.com
Earnings Scheduled For August 6, 2025

benzinga.com
Earnings Scheduled For May 8, 2025

benzinga.com
Earnings Scheduled For February 26, 2025

benzinga.com
Earnings Scheduled For February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los

benzinga.com
Earnings Scheduled For November 7, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

benzinga.com
Intuit To Rally More Than 20%? Here Are 10 Other Analyst Forecasts For Monday

Keybanc lowered the price target for Bumble Inc. (NASDAQ: BMBL) from $25 to $24. Keybanc analyst

benzinga.com
Earnings Scheduled For August 7, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss a

benzinga.com
Earnings Scheduled For May 9, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

benzinga.com
Earnings Scheduled For February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnin

benzinga.com
Earnings Scheduled For November 8, 2022

Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings a

benzinga.com
Earnings Scheduled For August 9, 2022

  Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor

benzinga.com
Earnings Scheduled For May 5, 2022

  Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report

benzinga.com
93 Biggest Movers From Friday

Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90.

benzinga.com
88 Biggest Movers From Yesterday

Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren rece

benzinga.com
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termin

Here's a roundup of top developments in the biotech space over the last 24 hours:

benzinga.com
Earnings Scheduled For November 9, 2021

  Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for it

benzinga.com
Earnings Scheduled For August 11, 2021

  Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earn

benzinga.com
Earnings Scheduled For May 12, 2021

  Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for

benzinga.com
Earnings Scheduled For February 25, 2021

  Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

    Before 10 a.m. ET on Wednesday, 192 companies set new 52-week highs.